These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 6091169

  • 1. The problem of cytomegalovirus infection in renal allograft recipients.
    Kurtz JB, Thompson JF, Ting A, Pinto A, Morris PJ.
    Q J Med; 1984; 53(211):341-9. PubMed ID: 6091169
    [Abstract] [Full Text] [Related]

  • 2. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ, Malaise J, Moreno A, Crespo M, Fernández-Cruz L, Euro-SPK Study Group.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [Abstract] [Full Text] [Related]

  • 3. Cytomegalo and herpes simplex virus infections in renal transplant recipients.
    Wertheim P, Slaterus KW, Geelen JL, van der Noordaa J, Wilmink JM.
    Scand J Urol Nephrol Suppl; 1985 May; 92():5-8. PubMed ID: 3008317
    [Abstract] [Full Text] [Related]

  • 4. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.
    Peterson PK, Balfour HH, Marker SC, Fryd DS, Howard RJ, Simmons RL.
    Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
    Kraat YJ, Stals FS, Christiaans MH, Lazzarotto T, Landini MP, Bruggeman CA.
    J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
    [Abstract] [Full Text] [Related]

  • 7. Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants.
    Marker SC, Howard RJ, Simmons RL, Kalis JM, Connelly DP, Najarian JS, Balfour HH.
    Surgery; 1981 Jun; 89(6):660-71. PubMed ID: 6264640
    [Abstract] [Full Text] [Related]

  • 8. Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation.
    Whelchel JD, Pass RF, Diethelm AG, Whitley RJ, Alford CA.
    Transplantation; 1979 Dec; 28(6):443-6. PubMed ID: 229592
    [Abstract] [Full Text] [Related]

  • 9. Four-year experience with exclusive use of cytomegalovirus antibody (CMV-Ab)-negative donors for CMV-Ab-negative kidney recipients.
    Ackermann JR, LeFor WM, Weinstein S, Kahana L, Shires DL, Tardif G, Baxter J.
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):469-71. PubMed ID: 2831644
    [Abstract] [Full Text] [Related]

  • 10. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J, Morales-Buenrostro LE, Correa-Rotter R, Muñoz-Trejo T, Zúñiga-Varga J, Cuéllar-González JV, Mayorga-Madrigal H, Vanegas-Carrero R, Aranda F, Rodríguez-Romo R, Herrera-Garcia C, González-Michaca L, Sierra-Madero JG.
    Rev Invest Clin; 2008 Feb; 60(5):365-74. PubMed ID: 19227433
    [Abstract] [Full Text] [Related]

  • 11. Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections.
    Baldwin WM, van Es A, Valentijn RM, van Gemert GW, Daha MR, Vanes LA.
    Clin Exp Immunol; 1982 Dec; 50(3):515-24. PubMed ID: 6299633
    [Abstract] [Full Text] [Related]

  • 12. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K, Sandhu S, Wu C, Muirhead N, Hollomby D, Jevnikar A.
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [Abstract] [Full Text] [Related]

  • 13. A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT).
    Zikos P, Van Lint MT, Lamparelli T, Gualandi F, Occhini D, Mordini N, Berisso G, Bregante S, Bacigalupo A.
    Haematologica; 1998 Feb; 83(2):132-7. PubMed ID: 9549924
    [Abstract] [Full Text] [Related]

  • 14. Prospective study of the prevalence and symptomatology of cytomegalovirus infection in renal transplant recipients.
    Chatterjee SN, Jordan GW.
    Transplantation; 1979 Dec; 28(6):457-60. PubMed ID: 229594
    [Abstract] [Full Text] [Related]

  • 15. Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival.
    Helanterä I, Koskinen P, Finne P, Loginov R, Kyllönen L, Salmela K, Grönhagen-Riska C, Lautenschlager I.
    Transpl Int; 2006 Nov; 19(11):893-900. PubMed ID: 17018124
    [Abstract] [Full Text] [Related]

  • 16. The effects of viral infections on renal transplants and their recipients.
    Warrell MJ, Chinn I, Morris PJ, Tobin JO.
    Q J Med; 1980 Nov; 49(194):219-31. PubMed ID: 6254109
    [Abstract] [Full Text] [Related]

  • 17. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
    Chen JH, Mao YY, He Q, Wu JY, Lv R.
    Transplant Proc; 2005 Dec; 37(10):4203-7. PubMed ID: 16387078
    [Abstract] [Full Text] [Related]

  • 18. Polyvalent immune globulin and cytomegalovirus infection after renal transplantation.
    Kasiske BL, Heim-Duthoy KL, Tortorice KL, Ney AL, Odland MD, Rao KV.
    Arch Intern Med; 1989 Dec; 149(12):2733-6. PubMed ID: 2556978
    [Abstract] [Full Text] [Related]

  • 19. Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients.
    Naumnik B, Małyszko J, Chyczewski L, Kovalchuk O, Małyszko J, Myśliwiec M.
    Transplant Proc; 2007 Nov; 39(9):2748-50. PubMed ID: 18021976
    [Abstract] [Full Text] [Related]

  • 20. Overt cytomegalovirus (CMV) infection following renal transplantation--usefulness of CFA, NIA, PENA antibodies as markers in serological diagnosis and evaluation of risk factors influencing the manifestations of CMV infection.
    Nakamura K.
    Tokai J Exp Clin Med; 1982 Nov; 7(6):631-53. PubMed ID: 6306871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.